Penobscot Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $684K | Hold |
8,740
| – | – | 0.06% | 193 |
|
|
2025
Q1 | $633K | Sell |
8,740
-6,258
| -42% | -$454K | 0.06% | 188 |
|
|
2024
Q4 | $1.11M | Buy |
+14,998
| New | +$1.11M | 0.1% | 152 |
|
|
2022
Q4 | – | Sell |
-2,427
| Closed | -$201K | – | 225 |
|
|
2022
Q3 | $201K | Hold |
2,427
| – | – | 0.04% | 217 |
|
|
2022
Q2 | $231K | Hold |
2,427
| – | – | 0.04% | 211 |
|
|
2022
Q1 | $286K | Hold |
2,427
| – | – | 0.04% | 207 |
|
|
2021
Q4 | $314K | Buy |
2,427
+27
| +1% | +$3.49K | 0.04% | 208 |
|
|
2021
Q3 | $272K | Hold |
2,400
| – | – | 0.04% | 211 |
|
|
2021
Q2 | $249K | Hold |
2,400
| – | – | 0.04% | 215 |
|
|
2021
Q1 | $201K | Hold |
2,400
| – | – | 0.03% | 218 |
|
|
2020
Q4 | $219K | Buy |
+2,400
| New | +$219K | 0.04% | 201 |
|